Sunday, June 16, 2024 10:58:34 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent IINN News
- Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency • GlobeNewswire Inc. • 02/25/2026 09:10:00 PM
- Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State • GlobeNewswire Inc. • 02/18/2026 01:32:00 PM
- Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks • GlobeNewswire Inc. • 02/17/2026 01:00:00 PM
- Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement • GlobeNewswire Inc. • 02/12/2026 09:01:00 PM
- Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment • GlobeNewswire Inc. • 02/09/2026 12:00:00 PM
- Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
- Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market • GlobeNewswire Inc. • 02/03/2026 02:22:00 PM
- ART100 Becomes Inspira’s First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center • GlobeNewswire Inc. • 01/29/2026 01:30:00 PM
- Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders • GlobeNewswire Inc. • 01/21/2026 01:50:00 PM
- Inspira Technologies shares advance after unveiling plans to enter liquid biopsy diagnostics • IH Market News • 01/08/2026 03:42:45 PM
- Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion • GlobeNewswire Inc. • 01/08/2026 01:50:00 PM
- CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation • GlobeNewswire Inc. • 01/05/2026 03:46:00 PM
- Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation • GlobeNewswire Inc. • 01/05/2026 02:30:00 PM
- Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones • GlobeNewswire Inc. • 12/23/2025 01:30:00 PM
- Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use • GlobeNewswire Inc. • 12/09/2025 01:05:00 PM
- Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology • GlobeNewswire Inc. • 12/03/2025 01:43:08 PM
- Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission • GlobeNewswire Inc. • 11/13/2025 02:00:00 PM
- Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion • GlobeNewswire Inc. • 11/06/2025 02:10:00 PM
- Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira’s Global Ecosystem • GlobeNewswire Inc. • 10/22/2025 12:30:00 PM
- Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm • GlobeNewswire Inc. • 10/21/2025 07:40:00 PM
- Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm • GlobeNewswire Inc. • 10/21/2025 01:05:00 PM
- Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update • GlobeNewswire Inc. • 10/01/2025 12:00:00 PM
- Inspira to Unveil HYLA™ Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed • GlobeNewswire Inc. • 09/18/2025 12:00:00 PM
- Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance • GlobeNewswire Inc. • 09/11/2025 01:30:00 PM
- Top U.S. Honor Roll Hospital Expands Use of INSPIRA™ ART100 System to Lung Transplant Procedures • GlobeNewswire Inc. • 09/02/2025 01:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

